Is semax or selank better?

Neither, in general. Semax scores 7.1 and selank 6.9, which is a tie in practice. Semax wins focus, with a cognition subrating of 6.5 against 4.5. Selank wins anxiety 6.5 against 3.5, mood 5.5 against 3.5, and stress resilience 6.0 against 4.0. Pick by which symptom is actually stopping you, then test it for 2 weeks.

Can you take semax and selank together?

Probably, though no trial has tested the pair, so this is inference from mechanism. They overlap at one pathway, enkephalinase inhibition, which Kost 2001 measured for both in human serum. Everything else is separate. Run them sequentially first. Two weeks of each alone, one marker written down before you start, semax in the morning. Selank's own report warns against stacking it with other nervous-system experiments simultaneously.

What is the difference between semax and selank?

Semax is an ACTH 4-7 heptapeptide that works through BDNF and TrkB, NGF, cholinergic modulation and melanocortin receptors, and it is used for attention. Selank is a tuftsin-derived heptapeptide that modulates GABA-A and serotonin and carries immune activity, and it is used for anxiety. Both are intranasal, Russian in origin, and unapproved in the West.

How fast do semax and selank work?

Both are noticeable within about an hour of intranasal dosing, which is unusually fast for this category. Both assess in 2 weeks. Semax reaches full effect at about 2 weeks and selank at about 14 days, so the timelines are effectively identical and a sequential test of both costs a month.

Which one is cheaper?

Semax, at typical doses. It is an ESTIMATED $12 to $60 a month priced 2026-09-07, based on a 30 mg 0.1% spray at $40 to $100 and a 300 to 600 mcg daily dose. Selank runs $30 to $60 a month from the source report. The bands overlap at the top and neither is expensive, so price should not pick your peptide.

Are semax and selank legal and safe to buy?

Both are gray market and both require purity verification. Semax is approved in Russia and unapproved in the US. Selank has no approved Western product at all. Both score 1.8 out of 5.0 on safety risk and side-effect profile, so the pharmacology looks benign in the published literature. The real risk is the vial: FDA flags selank acetate compounding for immunogenicity concerns, and neither peptide has a product standard.

Will semax or selank affect my sleep?

Semax can, in the wrong direction. It has no sleep data, and its acute effect can feel activating, so late dosing may disrupt sleep. Dose it in the morning. Selank scores 3.0 against semax's 2.0 because anxiety reduction can improve sleep onset in anxious users, but it is non-sedating and neither peptide has polysomnography behind it.

Head-to-Head Comparison

Semax vs Selank: Which Is Better for Focus and Anxiety?

Should I take semax or selank, and can I run both?

Reviewed 09/07/2026

Pick by symptom. Semax scores 7.1 and wins focus. Selank scores 6.9 and wins anxiety, mood and stress resilience. The 0.2 gap decides nothing. The mechanisms overlap at one enzyme and diverge everywhere else, so running both is defensible, but no trial has tested the pair.

Semax 7.1, selank 6.9. Both are gray-market Russian peptides with no FDA-approved product.
Focus goes to semax: cognition subrating 6.5 against selank's 4.5.
Anxiety goes to selank: 6.5 against semax's 3.5, and semax can make anxious users restless.
Mechanisms are complementary, not redundant. Selank modulates GABA-A and serotonin. Semax works through BDNF, TrkB, NGF and cholinergic signaling. They share only enkephalinase inhibition.
Both act within about an hour and both assess in 2 weeks, so a clean sequential test costs you a month.
Cheap either way. Semax is an ESTIMATED $12 to $60 a month, selank $30 to $60. Third-party testing matters more than price.

At a Glance

Option B

Selank

6.9 / 10 Worth trying

Upside

Efficacy 3.7
Breadth 3.5
Evidence 3.4
Speed 4.5
Durability 2.5
Bioindividuality 3.5

Downside

Safety Risk 1.8
Side Effects 1.8
Cost 2.0
Effort 2.0
Opportunity Cost 2.5
Dependency 1.8
Reversibility 1.5

Best at:

Anxiety 6.5
Stress Resilience 6.0
Mood 5.5
Immune Function 4.5

Tuftsin-derived heptapeptide anxiolytic, intranasal. BioHarmony 6.9, worth trying.

Read full BioHarmony report →

Head-to-Head Verdict

Use Case	Winner	Rationale
Cognition Focus	Semax	Semax, 6.5 against 4.5, and it is the clearest call in the matrix. The human signal is Russian attention and operative-memory work, including Asmarin 1997 and Kaplan 1996, backed by animal learning data in Dolotov 2006. Selank's own report describes it as cognition-preserving rather than cognition-transforming, which is a different job.
Anxiety	Selank	Selank, 6.5 against 3.5, and this is the reverse image of the focus row. Zozulia 2008 compared selank with medazepam in 62 patients with generalized anxiety or neurasthenia and reported similar anxiolytic effects. Semax has no controlled human anxiety trial at all, and its own report notes some users report restlessness rather than calm.
Mood	Selank	Selank, 5.5 against 3.5. Zozulia 2008 and Medvedev 2014 both tracked anxiety-spectrum patients where low mood travels with the anxiety, so the mood claim is adjunctive rather than primary. Semax has BDNF mechanisms that are relevant to mood biology and no controlled human mood trial. Neither is an antidepressant, and selank's edge here is modest.
Stress Resilience	Selank	Selank, 6.0 against 4.0. Kasian 2017 ran selank alone and combined with diazepam under chronic mild stress in rats, and Zozulia 2008 points the same way in humans. Semax has hypoxia and metabolic-stress animal models, including Ellis 2020, but no human stress, cortisol, HRV or resilience endpoint exists.
Flow State	Both (Stack)	The row where running both is the honest answer. Semax scores 4.5 on acute focus and mental-energy reports. Selank scores 3.5 on the inference that a lower threat response lets anxious users reach flow without sedation. Different halves of one problem, and the mechanisms do not collide. Be clear on the evidence: neither has a measured flow endpoint, and no trial has tested the pair.
Reaction Time	Semax	Semax, 4.0 against 2.5, on a thin base. Russian human work on attention and information processing suggests reaction-time relevance without a verified reaction-time RCT. Selank's claim is preservation rather than improvement: human comparator data show a lower cognitive burden than benzodiazepine comparators. Directional at best on both sides.
Social Bonding	Tie	Even, and both near the floor. Semax scores 2.0 on weak theoretical melanocortin relevance with no oxytocin, empathy or social-cognition evidence. Selank scores 3.0 on the reasonable idea that a lower social threat response helps anxious people, with no bonding endpoint measured. If social connection is the goal, neither peptide is the lever.
Sleep Quality	Selank	Selank, 3.0 against 2.0, and the actionable point is the direction of error. Anxiety reduction can improve sleep onset in anxious users, and selank's non-sedating profile means it is not a sleep drug. Semax has no sleep data and its acute effect can feel activating, so late dosing may disrupt sleep. Neither has polysomnography behind it. Dose semax in the morning.

Cost Comparison

Intervention	Monthly Cost	Notes
Semax	$12 to $60	ESTIMATE, priced 2026-09-07, research-chemical channel. A pre-mixed 30 mg 0.1% nasal spray runs $40 to $100. At 300 mcg a day, which is 9 mg a month, that is $12 to $30. At 600 mcg a day, 18 mg a month, it is $24 to $60. Vendor and concentration drive the spread, so a certificate of analysis matters more than the sticker price.
Selank	$30 to $60	Priced 2026-09-07 from the source report rather than estimated by us. The report puts typical gray-market intranasal use at $30 to $60 a month depending on vendor, concentration and daily dose. Third-party testing and cold-chain handling push you to the top of that band, and both are worth paying for.
The difference	About $20 a month at typical doses	Semax can be the cheaper of the two at a 300 mcg daily dose, roughly $12 to $30 against selank's $30 to $60. At the top of both bands they meet at $60.Neither is expensive enough for price to decide anything. Running both costs about $42 to $120 a month, which is still less than most nootropic stacks. Spend the difference on a vendor with third-party testing.

When to Switch

Both peptides are noticeable within about an hour and both assess in 2 weeks, which makes this the rare comparison you can settle by experiment instead of argument. Run one 2-week intranasal course, change nothing else, and judge it against a single marker you wrote down first.

Move from semax to selank when the 2 weeks produce restlessness, jitter or worse sleep rather than focus, which is a documented semax response in users with high baseline anxiety. Move from selank to semax when anxiety drops but attention stays flat, because selank preserves cognition rather than sharpening it.

On running both: the mechanisms are complementary and there is no pharmacological reason they collide, but no trial has tested the combination, so it is inference. The disciplined route is sequential. Test semax alone for 2 weeks, test selank alone for 2 weeks, then add the second only if each earned its place on its own, and dose semax in the morning so its activating effect does not land near bedtime. Do not layer either onto benzodiazepines, sedatives, alcohol or psychiatric medication without a clinician.

Who Should Pick What?

Attention is the bottleneck and your baseline anxiety is low

Semax

Cognition focus 6.5 against 4.5, reaction time 4.0 against 2.5. Semax is the one with human attention and operative-memory work behind it, thin as that literature is. Dose in the morning and give it 2 weeks against one written-down marker.

Situational anxiety before presentations, and you need to stay sharp

Selank

Anxiety 6.5 against 3.5, and the non-sedating profile is the point. Medvedev 2014 reported anxiolytic and mild nootropic effects against phenazepam in 60 anxiety-spectrum patients, which is the opposite of what a benzodiazepine does to your presentation.

High baseline anxiety that collapses your attention

Selank

Treat the anxiety first. High baseline anxiety is a listed reason to avoid semax, and its own report notes restlessness in some users. Fix the threat response with selank, then reassess whether focus is still a separate problem worth a second experiment.

Both problems are real and you will run two clean trials

Both (Stack)

The mechanisms are complementary and overlap only at enkephalinase inhibition, so there is no redundancy argument against the pair. There is also no trial. Run 2 weeks of each alone before combining, keep semax in the morning, and drop whichever one did not earn its slot.

Taking benzodiazepines, sedatives or psychiatric medication

Tie

Neither, without a clinician. Selank's report lists concurrent benzodiazepines and sedatives as reasons to avoid it, and semax lists MAOIs and psychiatric medication without clearance. Both interaction profiles are under-studied, which is a reason to ask rather than guess.

Drug-tested athlete, pregnant, breastfeeding, or with a seizure history

Tie

Neither. Pregnancy and breastfeeding rule out both reports. Seizure history rules out semax. WADA's S0 category can cover non-approved pharmacological substances, so neither peptide is safe for a tested athlete regardless of whether it is named on the list.

Research Highlights

Mechanism Difference
These two peptides are complementary rather than redundant, and they share exactly one arm. Semax signals through BDNF and TrkB, NGF, cholinergic modulation and low-affinity melanocortin receptors. Selank modulates GABA-A allosterically, affects serotonin and monoamine handling, and carries tuftsin-class immune activity.The overlap is enkephalin-degrading enzyme inhibition, which Kost 2001 measured for both peptides in human serum, plus BDNF signaling. One shared arm out of five is why the pair is a plausible stack and why they do not substitute for each other.
Safety Comparison
Safety is a draw on the numbers. Both score 1.8 out of 5.0 on safety risk and 1.8 on side-effect profile, and both share the same real hazard: no approved Western product, so identity, concentration and sterility depend on a vendor certificate of analysis.The exclusion lists differ in one useful way. Semax adds seizure history and high baseline anxiety. Selank adds concurrent benzodiazepines, sedatives and alcohol. Pregnancy, breastfeeding, unstable psychiatric symptoms and drug-tested sport rule out both.
Cost Comparison
Semax is an ESTIMATE of $12 to $60 a month, priced 2026-09-07, based on a 30 mg 0.1% nasal spray at $40 to $100 and a 300 to 600 mcg daily dose. Selank is $30 to $60 a month, taken from the source report rather than estimated, priced the same day.Running both lands around $42 to $120 a month. Neither price is high enough to decide anything, which means the money is better spent on a vendor that publishes third-party testing than on choosing the cheaper peptide.
Stacking Both
Can you run them together? Probably, and nobody has tested it. The mechanisms overlap at only one of five pathways, both are intranasal, both are noticeable within an hour, and both assess in 2 weeks, so a sequential trial costs a month and answers the question for your own physiology.Selank's own report warns against stacking it with other nervous-system experiments at the same time, which is the argument for sequence rather than simultaneity. Test each alone, then combine, and keep semax in the morning.
Editorial Verdict
Semax scores 7.1 and selank 6.9, a gap too small to act on, so symptom picks the peptide. Take semax when attention is the bottleneck: cognition focus 6.5 against 4.5, with Russian attention work and Dolotov 2006's BDNF and TrkB data behind it.Take selank when the threat response is the bottleneck: anxiety 6.5 against 3.5, mood 5.5 against 3.5, stress resilience 6.0 against 4.0, with Zozulia 2008's 62-patient medazepam comparison as the anchor. Both bodies of evidence are Russian, small and unreplicated in the West.

Frequently Asked Questions

Is semax or selank better?: Neither, in general. Semax scores 7.1 and selank 6.9, which is a tie in practice. Semax wins focus, with a cognition subrating of 6.5 against 4.5. Selank wins anxiety 6.5 against 3.5, mood 5.5 against 3.5, and stress resilience 6.0 against 4.0. Pick by which symptom is actually stopping you, then test it for 2 weeks.
Can you take semax and selank together?: Probably, though no trial has tested the pair, so this is inference from mechanism. They overlap at one pathway, enkephalinase inhibition, which Kost 2001 measured for both in human serum. Everything else is separate.Run them sequentially first. Two weeks of each alone, one marker written down before you start, semax in the morning. Selank's own report warns against stacking it with other nervous-system experiments simultaneously.
What is the difference between semax and selank?: Semax is an ACTH 4-7 heptapeptide that works through BDNF and TrkB, NGF, cholinergic modulation and melanocortin receptors, and it is used for attention. Selank is a tuftsin-derived heptapeptide that modulates GABA-A and serotonin and carries immune activity, and it is used for anxiety. Both are intranasal, Russian in origin, and unapproved in the West.
Does semax cause anxiety?: It can. Semax's anxiety subrating is 3.5 because the signal is mixed: some users report calm focus and others report restlessness. High baseline anxiety is a listed reason to avoid it, and no controlled human anxiety trial supports it either way. If anxiety is your main problem, selank is the better first test.
How fast do semax and selank work?: Both are noticeable within about an hour of intranasal dosing, which is unusually fast for this category. Both assess in 2 weeks. Semax reaches full effect at about 2 weeks and selank at about 14 days, so the timelines are effectively identical and a sequential test of both costs a month.
Which one is cheaper?: Semax, at typical doses. It is an ESTIMATED $12 to $60 a month priced 2026-09-07, based on a 30 mg 0.1% spray at $40 to $100 and a 300 to 600 mcg daily dose. Selank runs $30 to $60 a month from the source report. The bands overlap at the top and neither is expensive, so price should not pick your peptide.
Are semax and selank legal and safe to buy?: Both are gray market and both require purity verification. Semax is approved in Russia and unapproved in the US. Selank has no approved Western product at all.Both score 1.8 out of 5.0 on safety risk and side-effect profile, so the pharmacology looks benign in the published literature. The real risk is the vial: FDA flags selank acetate compounding for immunogenicity concerns, and neither peptide has a product standard.
Will semax or selank affect my sleep?: Semax can, in the wrong direction. It has no sleep data, and its acute effect can feel activating, so late dosing may disrupt sleep. Dose it in the morning. Selank scores 3.0 against semax's 2.0 because anxiety reduction can improve sleep onset in anxious users, but it is non-sedating and neither peptide has polysomnography behind it.

Evidence Sources

Preclinical Semax affects BDNF and trkB expression in rat hippocampus (2006) BDNF and TrkB upregulation after intranasal semax in rats, with a conditioned-learning signal. The main mechanistic anchor for semax.
Clinical study Nootropic analog of adrenocorticotropin 4-10 Semax (1997) Supports the attention and operative-memory direction in humans. Numbers were not independently verified in the source report's audit.
Clinical study Effects of Semax on human attention and memory (1996) Small human study reporting nootropic-like activity. Verified by DOI only, with no PMID found.
Preclinical Protection of episodic memory by Semax in hypoxic-exposed Sprague Dawley rats (2020) Animal-only hypoxia and novel-object-recognition support. The basis for semax's stress-resilience score, which has no human endpoint.
Clinical study Semax in combination with rehabilitation in post-ischemic stroke patients (2018) 110 post-stroke patients with BDNF and rehabilitation outcome direction. Semax's strongest human dataset, and a clinical population rather than a nootropic one.
Clinical trial Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia (2008) 62 patients, selank against medazepam, similar anxiolytic effects over a 14-day course. The key human anxiety anchor.
Clinical trial Comparison of Selank and phenazepam in anxiety disorders (2014) 60 anxiety-spectrum patients; anxiolytic effect plus a mild nootropic effect against a benzodiazepine comparator.
Clinical trial Optimization of anxiety-disorder treatment with Selank (2015) Selank added to phenazepam; fewer benzodiazepine-type tolerability problems and improved quality-of-life measures.
Review Peptide-based anxiolytics: molecular aspects of Selank biological activity (2018) GABA-receptor allosteric modulation as selank's primary mechanism, which is the pathway semax does not touch.
Preclinical Selank administration affects genes involved in GABAergic neurotransmission (2016) Rat frontal-cortex gene expression; 45 neurotransmission genes changed at one hour, consistent with the fast subjective onset.
Preclinical Selank enhances diazepam's anxiety-reducing effect under chronic mild stress in rats (2017) Rat stress model with individual and combined selank plus diazepam arms. The anchor for selank's stress-resilience score.
Mechanistic Semax and Selank inhibit enkephalin-degrading enzymes from human serum (2001) Both peptides measured against the same enzyme target in human serum, with selank IC50 around 20 microM. The only shared mechanism between them.
Clinical study Immunomodulatory effects of Selank in anxiety-asthenic disorders (2008) Human cytokine and immune-modulation work. Selank's tuftsin-class immune activity is its clearest non-anxiety lane, and semax has no equivalent.
Regulatory FDA: certain bulk drug substances for use in compounding may present significant safety risks (2026) Regulatory uncertainty for both peptides. FDA flags selank acetate compounding for immunogenicity concerns and limited human safety information.
Regulatory WADA: what is prohibited (2026) Explains the S0 non-approved substance category, which can cover both peptides even though neither is named on the list.

Glossary

Quick reference for the medical and technical terms used in this comparison.

BDNF Brain-Derived Neurotrophic Factor: A growth factor that supports neuron survival and signaling. Both peptides touch it, and it is semax's primary mechanism (Dolotov 2006).
TrkB Tropomyosin Receptor Kinase B: The receptor BDNF binds to. Semax upregulates both together in rat hippocampus, which is the basis of its cognitive rationale.
NGF Nerve Growth Factor: A second neurotrophic factor in semax's target list. Selank does not act on it.
GABA-A Gamma-Aminobutyric Acid type A receptor: The main inhibitory receptor in the brain and the target benzodiazepines hit hard. Selank modulates it allosterically, which is why it calms without sedating.
Enkephalinase Enkephalin-degrading enzymes: Enzymes that break down the body's own opioid peptides. The one mechanism both peptides share, measured for each in human serum by Kost 2001.
Tuftsin Tuftsin: An immune-active peptide fragment. Selank is derived from it, which is where its cytokine and immune-modulation activity comes from.
ACTH 4-7 Adrenocorticotropic hormone fragment 4-7: The hormone fragment semax is built on, joined to a proline-glycine-proline tail for stability. It has no hormonal ACTH activity.
Melanocortin receptors Melanocortin receptors: A receptor family semax touches with low affinity. The basis of its weak theoretical social-bonding relevance, which has no supporting evidence.
GAD Generalized Anxiety Disorder: The diagnosis in Zozulia 2008's 62-patient selank trial, alongside neurasthenia.
Neurasthenia Neurasthenia: A post-Soviet clinical term for chronic fatigue with irritability and poor concentration. Common in the Russian selank literature.
S0 WADA non-approved substances category: The catch-all that prohibits any pharmacological substance with no current regulatory approval for human therapeutic use. It can cover both peptides.
COA Certificate of Analysis: A vendor's third-party test of identity and purity. With no approved product on either side, it is the only quality signal you get.

Nick Urban Health Optimization Researcher & CHEK Holistic Lifestyle Coach Level 2

Semax was the first nootropic peptide I tried and I still use it several times a month as a nasal spray

Reviewed Sep 7, 2026 · next review Dec 6, 2026

Find which one fits your biology

Take the BioHarmony Quiz